Tag : License

Latest News

Genentech Submits Supplemental Biologics License Application to FDA for Kadcyla for Adjuvant Treatment of People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment

Newsemia
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced completing the submission of a supplemental Biologics...
Biology

2Blades Announces Completion of a Non-exclusive License With Epicrop Technologies Inc. For Access to the TAL Code Technology

Newsemia
EVANSTON, Ill. (PRWEB) November 05, 2018 2Blades has completed a non-exclusive license agreement with Epicrop Technologies Inc., for access to 2Blades’ Transcription Activator Like (TAL) effector...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy